TG Therapeutics Inc (USD)
TGTX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range9.69 | 10.20
52-Wk Range |
Last Close9.77
Mkt Cap (m)1,068.85
Dividend yield-
ISINUS88322Q1085
Volume1,535,996
Exchange VenueNAS

Company Profile

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

Key Information
Price/Earning-
Price/Book27.70
Price/Sales5680.02
P/CF-
Rev Growth (3 year avg)-0.08
EPS Growth (3 year avg)-
Operating Margin % -111220.39
Net Margin %-113730.92
Return on Equity-551.85
Debt/Equity1.06

Documents

Prospectus
en 20/03/2020
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)
Operating Income (m)-56-63-79-119-174-169
Net Income (m)-56-63-78-118-173-173
Basic EPS-1.64-1.38-1.60-1.91-2.30-1.96
Avg. Diluted Shares Outstanding (m)344649627588
Balance Sheet
USD201420152016201720182019
Current Assets (m)8587519379149
Non Current Assets (m)22744514
Total Assets (m)87113559784163
Current Liabilities (m)51117283984
Total Liabilities (m)------
Total Equity (m)8010236672439
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-35-45-62-94-129-133
Capital Expenditure (m)
Figures are quoted in USD unless stated otherwise
-
No change
$
9.77
Last Price